معرفی
Clinical Professor Paul Roach is affiliated with the University of Sydney's Northern Clinical School, specializing in Medical Imaging. His research focuses on diagnostic imaging techniques (e.g., PET/CT, SPECT/CT) applied to neuroendocrine tumors, thyroid cancer, and oncology. He has contributed to advancements in theranostic approaches, biomarker development, and radiation therapy protocols.
Key research interests include:
- Peptide receptor radionuclide therapy (PRRT) efficacy and safety
- PET/CT imaging for neuroendocrine neoplasms
- Prognostic biomarkers like NETPET score
- Thyroid cancer management and radioactive iodine practices
Recent articles highlight innovations in dual modality imaging, PRRT outcomes, and biomarker validation. His work has been published in journals like Journal of Nuclear Medicine and Theranostics. Collaborative grants include studies on nasal mesh nebulizers and thyroid cancer management.
Notable projects include the TROG 18.06 glioblastoma trial and the Australasian consensus on hormonal crises during PRRT. His clinical expertise bridges molecular imaging with oncological treatment strategies.
